Utility of Therapeutic Drug Management (TDM) in Managing Plazomicin Pharmacokinetic (PK) Variability in Patients With Infections Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.